+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Specialty Enzymes Market - Global Outlook & Forecast 2022-2027

  • PDF Icon


  • 221 Pages
  • January 2023
  • Region: Global
  • Arizton
  • ID: 5714635
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global specialty enzymes market is expected to grow at a CAGR of 7.46% during 2022-2027. - Factors such as the rapidly increasing global population, increasing research & development, spreading new infectious diseases, increasing biofuel usage, and growing agriculture industry led to increased demand for specialty enzymes in the global market. The major drivers of the specialty enzymes market include the increasing health consciousness and intense penetration of the pharmaceutical, diagnostics, and biotechnology industries.
  • Specialty enzymes are used in various industries for various purposes. In the pharmaceutical industry, these are used for manufacturing drugs for DNA/RNA treatment, cancer, heart-related disease, and other treatments. The demand is increasing due to increasing awareness and changing government policies. With the growing specialty enzymes markets, companies must increase the supply of raw materials to produce enzymes in bulk quantities. In the pharmaceutical industry, companies have started using biobased drugs to improve product quality. Companies are adopting sustainable standards in their manufacturing processes. The specialty enzymes market has helped to reduce the by-products in the production process. Companies are getting good financial returns by using specialty enzymes in the production processes. Thus, the global demand for specialty enzymes is increasing.
  • The US contributed more than half of the overall demand in North America. Globally, the demand for specialty enzymes is very high in the US, and North America dominates the global specialty enzymes market. The US has the world’s top 10 pharmaceutical companies’ head offices. Thus, the demand for specialty enzymes in North America's pharmaceutical industry is increasing with the growing pharmaceutical industry.


Increased Use in Diagnostics Sector

  • The diagnostics industry includes two categories such as pathology and radiology. Pathology is used for testing all types of illness, whereas radiology is used for testing images related to diagnoses such as x-rays, CT scans, and others. For the research & development of vaccines for various infectious diseases, enzymes are used. Enzymes are used in testing infectious diseases such as coronaviruses and influenza and are also used in nucleic acid detection. The enzymes are used in the diagnostics and analysis of biological abnormalities.
  • The diagnostics segment plays a crucial role in the healthcare sector. After the Covid-19 pandemic, the demand for proper diagnostic equipment and processes in the diagnostics sector is growing rapidly. In the testing of coronaviruses and other infectious diseases, enzymes are used. For immediate recovery from coronavirus diseases, antibiotics are used, which are produced from enzymes. Thus, the specialty enzymes market in the diagnostic sector is increasing globally.

Increasing Demand from Pharmaceutical Industry

  • The global revenue of the pharmaceutical industry is increasing due to the global demand for pharmaceutical products. The factors driving the demand for pharmaceutical products include changing clinical practices, aging-related issues, and rising chronic diseases. After the Covid-19 pandemic, the demand for pharmaceutical products used to improve quality of life and preventive approach. The global market of pharmaceutical drugs is increasing due to the lowering the regulatory barrier for new drugs in the US.
  • The health consciousness of people has increased after the Covid-19 pandemic. People prefer bio-based pharmaceutical products. Thus, the demand for bio-based substances used in manufacturing antibiotics is rising. Specialty enzymes are used in the pharmaceutical industry to increase the reaction rate and produce the desired molecules, contributing to the specialty enzymes market growth.


Technical Barriers Affecting Specialty Enzymes Market

  • Biocatalysis is a process that accelerates the chemical process by using biomolecules. It includes mild reaction and high selectivity conditions. Therefore, specialty enzymes play an essential role in the chemical industry and are gaining relevance in industrial applications. But, there is difficulty in finding the accurate protein structure of specialty enzymes. The process is time-consuming and requires more catalysts to fulfilling the need of the chemical reaction process. For the manufacturing process of these enzymes, specific conditions such as new concentration, new substrate, and other conditions are required which are not found readily in nature. These unresolved challenges make specialty enzymes unpredictive. Thus, more research & development is necessary for making enzymes in bulk amounts, creating a barrier to the specialty enzymes market growth.



In the pharmaceutical industry, specialty enzymes are very useful and good for treating various diseases. As there is increasing demand for pharmaceutical products, the enzyme has become essential to meet the demand for sustainable and safe industry processes. The specialty enzymes are primarily used in the pharmaceutical and biotechnology industry for research & development and diagnostics. The global specialty enzymes market in the pharmaceutical industry was valued at USD 976.56 million in 2021. The demand for specialty enzymes in North America and APAC is very high due to the increasing pharmaceutical and biotechnology industry.

In the biotechnology industry, specialty enzymes are used to increase biochemical reaction rates. Lipases are used in dietary drugs and it is used to increase the metabolism rate. Polymerases & nucleases are used in DNA amplification. In DNA amplification, the increase in the number of the gene causes an increase in proteins and RNA. Thus, it may increase the cancer cells or lower the anticancer cells. Hence, the polymerases & nucleases-based enzymes demand is growing in the global specialty enzymes market.

Segmentation by End Use

  • Pharmaceutical
  • Biotechnology
  • Diagnostics
  • Other Specialty


Carbohydrases have dominated the global specialty enzymes market and is expected to reach USD 1.9 billion by 2027. Carbohydrases are mainly used in the pharmaceutical industry as specialty enzymes. Most of these enzymes used in the pharmaceutical industry are produced from microorganisms, animals, and plants. Carbohydrases are further classified into glucosidase, pectinases, alpha, beta amylases, cellulases, mannanases, galacto, and pullulanase. These are the cost-effective processes in industrial applications; thus, a cheap technique is required to obstruct.

The global proteases-based specialty enzymes market surpassed USD813 million in 2021. The proteases are used in the biotechnology, pharmaceutical, and diagnostics industries - the high use of proteases in the pharmaceutical industry for prognostic and diagnostic biomarkers. Based on the catalysis mechanism, the proteases are classified into additional classes, such as glutamic, aspartic, metalloproteases, threonine, cysteine, and serine proteases which activate the water molecule and attack the proteins.

Segmentation by Type

  • Carbohydrase
  • Proteases
  • Lipases
  • Polymerases & nucleases


Globally, microorganisms-based enzymes contributed 77.47%, followed by animal and plant-based enzymes in 2021 in the global specialty enzymes market. The demand for specialty enzymes is very high in North America, followed by Europe and APAC. Microorganisms and plant-based enzymes are easily found in the environment. Animal-based enzymes have fewer resources, and it isn't easy to produce in bulk quantities. Thus, companies are focusing on producing enzymes from microorganisms and plants.

The global plants-based specialty enzymes market was valued at USD 297.07 million in 2021. These are used in the agriculture industry to reduce insects from crops. The few plant-based enzymes are phosphatase, esterase, glucanase, chitinase, and others. These enzymes play a crucial role in the production of nutrition. Further, plant-based enzymes are being used to manufacture drugs in the pharmaceutical industry to improve the digestive system.

Segmentation by Source

  • Microorganisms
  • Plants
  • Animal


The global specialty enzymes market is diverse, with many established and potential growth markets. North America is the leading market because of rapidly developing infrastructure and readily increasing population, increasing demand for various pharmaceutical, biotechnology, and diagnostics industries. The specialty enzymes market in North America was valued at USD 1.2 billion in 2021.

Europe is the second-largest market for specialty enzymes. The growth is supported by the increasing demand for healthy pharmaceutical products, which is attributed to the rising health consciousness. Germany, France, Italy, Spain, the UK, Russia, and others led the region. In European countries, various companies are producing specialty enzymes that contribute to the global specialty enzymes market, such as BASF SE (Germany), Johnson Matthey (UK), Biocatalysts (UK), BBI Solutions (UK), and others. Furthermore, the demand is expected to grow significantly as the APAC region population has grown tremendously in recent years. China, Japan, India, and South Korea led the region. The population of APAC countries is increasing rapidly; thus, demand for pharmaceutical and diagnostics specialty enzymes is increasing. China, India, and Japan are the major pharmaceutical industry players in the APAC region.

Segmentation by Geography

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • UK
  • Russia
  • Rest of Europe
  • APAC
  • China
  • Japan
  • India
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA


The major companies in the specialty enzymes market are following the merger and acquisition strategy. This gives companies a competitive advantage that boosts their market share of the company. The key companies have undertaken various strategies to grow in the market. The growth in sustainable processes and initiatives has challenged all companies globally. Investments in R&D, technological advancement, and environmental and economic challenges drive the demand for innovative and sustainable specialty enzyme products.

Some major players in the global specialty enzymes market include Roche (Switzerland), BASF SE (Germany), DuPont (US), Novozymes (Denmark), and DSM (Netherlands). These players have adopted strategies like acquisitions, expansion, joint ventures, new product development, and others to increase their revenues in the industry. Other prominent companies such as Chr. Hansen Holding A/S (Denmark), Codexis (US), BBI Solutions (UK), and others have invested significant capital in R&D to develop specialty enzymes-based products that will appeal to customers. Therefore, these other prominent companies are giving tough competition to major companies.

Key Vendors

  • DSM
  • DuPont
  • F. Hoffmann-La Roche Ltd
  • Novozymes

Other Prominent Vendors

  • Amano Enzyme Inc.
  • Amayra Biotech AG
  • Antozyme Biotech Pvt Ltd
  • Aumgene Biosciences
  • Aumenzymes
  • BBI Solutions
  • Biocatalysts
  • Codexis
  • Hansen Holding A/S
  • Dyadic International Inc.
  • Iosynth
  • Merck KGaA
  • Nature Bioscience Pvt. Ltd.
  • Specialty Enzymes & Probiotics
  • Zymtronix Inc.


1. What was the global specialty enzymes market size in 2021?
2. What is the growth rate of the global specialty enzymes market?
3. What are the key trends in the Specialty Enzymes Market in the world?
4. Which are the key companies in the global specialty enzymes market?
5. Which end-use segment is estimated to lead the Global Specialty Enzymes Market?
Frequently Asked Questions about the Specialty Enzymes Market

What is the estimated value of the Specialty Enzymes Market?

The Specialty Enzymes Market was estimated to be valued at $2966.26 Million in 2021.

What is the growth rate of the Specialty Enzymes Market?

The growth rate of the Specialty Enzymes Market is 7.4%, with an estimated value of $4568.73 Million by 2027.

What is the forecasted size of the Specialty Enzymes Market?

The Specialty Enzymes Market is estimated to be worth $4568.73 Million by 2027.

Who are the key companies in the Specialty Enzymes Market?

Key companies in the Specialty Enzymes Market include BASF SE, DSM, DuPont, F. Hoffmann, La Roche Ltd, Novozymes, Amano Enzyme Inc., Amayra Biotech AG, Antozyme Biotech Pvt Ltd and Aumgene Biosciences.

Table of Contents

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of the Study
4.3.1 Market Segmentation by Geography

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Premium Insights
6.1 Introduction
6.2 Market Synopsis
6.2.1 Drivers
6.2.2 Opportunity
6.2.3 Challenges
6.3 Segment Review
6.3.1 End-Use
6.3.2 Type
6.3.3 Source
6.3.4 Geography
6.4 Companies & Strategies

7 Market at a Glance
8 Introduction
8.1 Overview
8.2 Value Chain Analysis
8.2.1 Raw Materials
8.2.2 Specialty Enzyme Manufacturers
8.2.3 Distributors
8.2.4 Applications
8.3 Macroeconomic Factors
8.3.1 Pharmaceutical Industry

9 Market Opportunities & Trends
9.1 Demand from Pharmaceutical Industry
9.2 Adoption of Sustainability Standards to Improve Profitability & Productivity
9.3 Demand from Emerging Economies

10 Market Growth Enablers
10.1 Demand for Bio-Sourced Products
10.2 Increased Use in Diagnostics Sector
10.3 Increased R&D & Product Innovation in Developed Countries

11 Market Restraints
11.1 Lack of Awareness of Bio-Based Products
11.2 Existence of Various Technical Barriers
11.3 High Manufacturing Cost

12 Market Landscape
12.1 Market Overview
12.2 Market Size & Forecast
12.3 Five Forces Analysis
12.3.1 Threat of New Entrants
12.3.2 Bargaining Power of Suppliers
12.3.3 Bargaining Power of Buyers
12.3.4 Threat of Substitutes
12.3.5 Competitive Rivalry

13 by Type
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Carbohydrases
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Market by Geography
13.4 Proteases
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Market by Geography
13.5 Lipases
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Market by Geography
13.6 Polymerases & Nucleases
13.6.1 Market Overview
13.6.2 Market Size & Forecast
13.6.3 Market by Geography
13.7 Other
13.7.1 Market Overview
13.7.2 Market Size & Forecast
13.7.3 Market by Geography

14 by End-Use
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Pharmaceutical
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Market by Geography
14.4 Biotechnology
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Market by Geography
14.5 Diagnostics
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Market by Geography
14.6 Other End-Use
14.6.1 Market Overview
14.6.2 Market Size & Forecast
14.6.3 Market by Geography

15 by Source
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Microorganism
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.3.3 Market by Geography
15.4 Plant
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.4.3 Market by Geography
15.5 Animal
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.5.3 Market by Geography

16 Geography
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview

17 North America
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Type
17.3.1 Market Size & Forecast
17.4 End-Use
17.4.1 Market Size & Forecast
17.5 Source
17.5.1 Market Size & Forecast
17.6 Key Countries
17.7 US
17.7.1 Market Size & Forecast
17.8 Canada
17.8.1 Market Size & Forecast

18 Europe
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Type
18.3.1 Market Size & Forecast
18.4 End-Use
18.4.1 Market Size & Forecast
18.5 Source
18.5.1 Market Size & Forecast
18.6 Key Countries
18.7 Germany
18.7.1 Market Size & Forecast
18.8 France
18.8.1 Market Size & Forecast
18.9 Italy
18.9.1 Market Size & Forecast
18.10 Spain
18.10.1 Market Size & Forecast
18.11 UK
18.11.1 Market Size & Forecast
18.12 Russia
18.12.1 Market Size & Forecast
18.13 Rest of Europe
18.13.1 Market Size & Forecast

19 Apac
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Type
19.3.1 Market Size & Forecast
19.4 End-Use
19.4.1 Market Size & Forecast
19.5 Source
19.5.1 Market Size & Forecast
19.6 Key Countries
19.7 China
19.7.1 Market Size & Forecast
19.8 Japan
19.8.1 Market Size & Forecast
19.9 India
19.9.1 Market Size & Forecast
19.10 South Korea
19.10.1 Market Size & Forecast
19.11 Rest of Apac
19.11.1 Market Size & Forecast

20 Middle East & Africa
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Type
20.3.1 Market Size & Forecast
20.4 End-Use
20.4.1 Market Size & Forecast
20.5 Source
20.5.1 Market Size & Forecast
20.6 Key Countries
20.7 Saudi Arabia
20.7.1 Market Size & Forecast
20.8 South Africa
20.8.1 Market Size & Forecast
20.9 Rest of Middle East & Africa
20.9.1 Market Size & Forecast

21 Latin America
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Type
21.3.1 Market Size & Forecast
21.4 End-Use
21.4.1 Market Size & Forecast
21.5 Source
21.5.1 Market Size & Forecast
21.6 Key Countries
21.7 Brazil
21.7.1 Market Size & Forecast
21.8 Mexico
21.8.1 Market Size & Forecast
21.9 Rest of Latin America
21.9.1 Market Size & Forecast

22 Competitive Landscape
22.1 Competition Overview
22.2 Recent Developments

23 Key Company Profiles
23.1 Basf Se
23.1.1 Business Overview
23.1.2 Financial Overview
23.1.3 Product Offerings
23.1.4 Key Strategies
23.1.5 Key Strengths
23.1.6 Key Opportunities
23.2 Dsm
23.2.1 Business Overview
23.2.2 Financial Overview
23.2.3 Product Offerings
23.2.4 Key Strategies
23.2.5 Key Strengths
23.2.6 Key Opportunities
23.3 Dupont
23.3.1 Business Overview
23.3.2 Financial Overview
23.3.3 Product Offerings
23.3.4 Key Strategies
23.3.5 Key Strengths
23.3.6 Key Opportunities
23.4 F. Hoffmann-La Roche Ltd
23.4.1 Business Overview
23.4.2 Financial Overview
23.4.3 Product Offerings
23.4.4 Key Strategies
23.4.5 Key Strengths
23.4.6 Key Opportunities
23.5 Novozymes
23.5.1 Business Overview
23.5.2 Financial Overview
23.5.3 Product Offerings
23.5.4 Key Strategies
23.5.5 Key Strengths
23.5.6 Key Opportunities

24 Other Prominent Vendors
24.1 Amano Enzyme Inc.
24.1.1 Company Overview
24.1.2 Business Overview
24.1.3 Product Offerings
24.2 Amyra Biotech AG
24.2.1 Company Overview
24.2.2 Product Offerings
24.3 Antozyme Biotech Pvt Ltd
24.3.1 Company Overview
24.3.2 Business Overview
24.3.3 Product Offerings
24.4 Aumgene Biosciences
24.4.1 Company Overview
24.4.2 Business Overview
24.4.3 Product Offerings
24.5 Aumenzymes
24.5.1 Company Overview
24.5.2 Product Offerings
24.6 Bbi Solutions
24.6.1 Company Overview
24.6.2 Business Overview
24.6.3 Product Offerings
24.7 Biocatalysts
24.7.1 Company Overview
24.7.2 Business Overview
24.7.3 Product Offerings
24.8 Codexis
24.8.1 Company Overview
24.8.2 Business Overview
24.8.3 Product Offerings
24.9 Chr. Hansen Holding A/S
24.9.1 Company Overview
24.9.2 Business Overview
24.9.3 Product Offerings
24.10 Dyadic International Inc.
24.10.1 Company Overview
24.10.2 Business Overview
24.10.3 Product Offerings
24.11 Iosynth
24.11.1 Company Overview
24.11.2 Business Overview
24.11.3 Product Offerings
24.12 Merck Kgaa
24.12.1 Company Overview
24.12.2 Business Overview
24.12.3 Product Offerings
24.13 Nature Bioscience Pvt. Ltd.
24.13.1 Company Overview
24.13.2 Business Overview
24.13.3 Product Offerings
24.14 Specialty Enzymes & Probiotics
24.14.1 Company Overview
24.14.2 Business Overview
24.14.3 Product Offerings
24.15 Zymtronix, Inc.
24.15.1 Company Overview
24.15.2 Product Offerings

25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations

26 Quantitative Summary
26.1 Type
26.1.1 Carbohydrases
26.1.2 Proteases
26.1.3 Lipases
26.1.4 Polymerases & Nucleases
26.1.5 Other
26.2 End-Use
26.2.1 Pharmaceutical
26.2.2 Biotechnology
26.2.3 Diagnostics
26.2.4 Other End-Use
26.3 Source
26.3.1 Microorganism
26.3.2 Plant
26.3.3 Animal
26.4 Geography
26.5 North America
26.5.1 Type
26.5.2 End-Use
26.5.3 Source
26.6 Europe
26.6.1 Type
26.6.2 End-Use
26.6.3 Source
26.7 Apac
26.7.1 Type
26.7.2 End-Use
26.7.3 Source
26.8 Middle East & Africa
26.8.1 Type
26.8.2 End-Use
26.8.3 Source
26.9 Latin America
26.9.1 Type
26.9.2 End-Use
26.9.3 Source

27 Appendix
27.1 Abbreviations

Companies Mentioned

  • DSM
  • DuPont
  • F. Hoffmann-La Roche Ltd
  • Novozymes
  • Amano Enzyme Inc.
  • Amayra Biotech AG
  • Antozyme Biotech Pvt Ltd
  • Aumgene Biosciences
  • Aumenzymes
  • BBI Solutions
  • Biocatalysts
  • Codexis
  • Hansen Holding A/S
  • Dyadic International Inc.
  • Iosynth
  • Merck KGaA
  • Nature Bioscience Pvt. Ltd.
  • Specialty Enzymes & Probiotics
  • Zymtronix Inc.


Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.

Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.